The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Hypertension Awareness, Treatment, and Control in Adults With CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) Study
Open accessAbstract
Background A low rate of blood pressure control has been reported in patients with chronic kidney disease (CKD). These data were derived from population-based samples with a low rate of CKD awareness.Study design Cross-sectional.Setting & participants Data from the baseline visit of the Chronic Renal Insufficiency Cohort (CRIC) Study (n = 3,612) were analyzed. Participants with an estimated glomerular filtration rate of 20-70 mL/min/1.73 m(2) were identified from physician offices and review of laboratory databases.Outcomes Prevalence and awareness of hypertension, treatment patterns, control rates, and factors associated with hypertension control.Measurements Following a standardized protocol, blood pressure was measured 3 times by trained staff, and hypertension was defined as systolic blood pressure > or =140 mm Hg and/or diastolic blood pressure > or =90 mm Hg and/or self-reported antihypertensive medication use. Patients' awareness and treatment of hypertension were defined using self-report, and 2 levels of hypertension control were evaluated: systolic/diastolic blood pressure <140/90 and <130/80 mm Hg.Results The prevalence of hypertension was 85.7%, and 98.9% of CRIC participants were aware of this diagnosis and 98.3% were treated with medications, whereas 67.1% and 46.1% had hypertension controlled to <140/90 and <130/80 mm Hg, respectively. Of CRIC participants with hypertension, 15%, 25%, 26%, and 32% were using 1, 2, 3, and > or =4 antihypertensive medications, respectively. After multivariable adjustment, older patients, blacks, and those with higher urinary albumin excretion were less likely, whereas participants using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers were more likely to have controlled their hypertension to <140/90 and <130/80 mm Hg.Limitations Data were derived from a single study visit.Conclusions Despite almost universal hypertension awareness and treatment in this cohort of patients with CKD, rates of hypertension control were suboptimal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Difficulty controlling BP in late stages of CKD was also seen in CRIC (Chronic Renal Insufficiency Cohort), in which 88% of participants had stage 3 or 4 CKD.”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [303]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Effect of Aerobic Exercise on Blood Pressure: A Meta-Analysis of Randomized, Controlled Trials
Whelton, S. P., Chin, A., Xin, X., & He, J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-7-200204020-00006 · Cited by 1,970
Predictors of New-Onset Kidney Disease in a Community-Based Population
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.291.7.844 · Cited by 1,241
Whelton, P. K., Appel, L. J., Espeland, M. A., Applegate, W. B., Ettinger, Jr., Kostis, J. B., Kumanyika, S., Lacy, C. R., Johnson, K. C., Folmar, S., et al. (1998) · JAMA · doi:10.1001/jama.279.11.839 · Cited by 1,200
Effects of Alcohol Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials
Xin, X., He, J., Frontini, M. G., Ogden, L. G., Motsamai, O. I., & Whelton, P. K. (2001) · Hypertension · doi:10.1161/hy1101.093424 · Cited by 738
The Chronic Renal Insufficiency Cohort (CRIC) Study
Feldman, H. I., Appel, L. J., Chertow, G. M., Cifelli, D., Čižman, B., Daugirdas, J. T., Fink, J. C., Franklin-Becker, E. D., Go, A. S., Hamm, L. L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070149.78399.ce · Cited by 660
Self-citationPrevalence of High Blood Pressure and Elevated Serum Creatinine Level in the United States
Coresh, J., Wei, G. L., McQuillan, G. M., Brancati, F., Levey, A. S., Jones, C. A., & Klag, M. J. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.9.1207 · Cited by 579
Traditional and Nontraditional Risk Factors Predict Coronary Heart Disease in Chronic Kidney Disease
Muntner, P., He, J., Astor, B. C., Folsom, A. R., & Coresh, J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080656 · Cited by 490
Self-citation
Cited by
Sorted by citations
Items 301–400 of 423
Aslam, N., Missick, S., & Haley, W. E. (2019) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.02.001 · Cited by 2
Burnier, M., Viazzi, F. C., Leoncini, G., Wuerzner, G., & Pontremoli, R. (2020) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-030-45562-0_1 · Cited by 3
Riaz, S., Nisa, Z. U., Mushtaq, S., Ijaz, Q. A., Sohail, K., & Khan, A. (2021) · Journal of Pharmacy Practice and Community Medicine · doi:10.5530/jppcm.2021.2.8 · Cited by 2
Okpechi, I. G., Ringrose, J., Padwal, R. S., & Bello, A. K. (2023) · Connected Health · doi:10.20517/ch.2022.18 · Cited by 2
Ballegaard, E. L. F., Carlson, N., Jørgensen, M. B., Sørensen, I. M. H., Trankjær, H., Almarsdóttir, A. B., Bro, S., Feldt‐Rasmussen, B., Kamper, A., & for The Copenhagen CKD Cohort Study Group (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae158 · Cited by 2
“However, both in our cohort and in other national cohorts of patients with CKD without KRT [10 , 12 –16 , 18 –22 ], reaching treatment targets remain difficult.”
BackgroundInfluentialDehkhoda, B., Enayati, A., Mirzaei, H., Ghorbani, S., Soleimani, M. H., Amirkhanlou, S., & Sahebkar, A. (2024) · PubMed Central · doi:10.22038/ajp.2024.23871 · Cited by 2
Vea, K. D., Nguyen, L.-A., McGill, K., Park, J. C., & Selevan, D. C. (2024) · The Permanente Journal · doi:10.7812/tpp/23.143 · Cited by 2
Wang, L., Liu, Y., Zhang, S., Li, J., Cui, Y., Yun, Y., Ma, X., & Zhang, H. (2025) · European journal of medical research · doi:10.1186/s40001-025-02475-w · Cited by 2
Microphysiological Uremia Model Reveals Biophysical Potentiators of Vascular Dysfunction
Rathod, M., Stack, R. N., Kubik, S. E., Huang, S. A., Whitworth, C. P., Aw, W. Y., Doherty, E. L., Meehan, S. M., Roy‐Chaudhury, P., & Polacheck, W. J. (2025) · Advanced Science · doi:10.1002/advs.202417091 · Cited by 2
Okpechi, I. G., Muneer, S., Tinwala, M. M., Zaidi, D., Hamonic, L. N., Braam, B. G., Jindal, K. K., Klarenbach, S. W., Padwal, R. S., Shojai, S., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044195 · Cited by 2
McFadden, C. B. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.11.003 · Cited by 2
Hipertensión arterial en la enfermedad renal crónica
López, R. O., Andreu, M. L., García-Montemayor, V., & Olmo, R. S. (2023) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2023.06.019 · Cited by 2
Lin, H. Y., Chang, Y.-H., Wang, Y., Liang, P., Hung, C., Chang, J., Dai, D., Lin, C., & Chang, K. (2023) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v52n10p510 · Cited by 2
Zhu, Q., Huo, Z., Zeng, F., Gong, N., Ye, P., Pan, J., Kong, Y., Dou, X., Wang, D., Huang, S., et al. (2024) · American Journal of Hypertension · doi:10.1093/ajh/hpae010 · Cited by 2
Ranasinghe, P. D., Manchanayake, M., Perera, T., Liyanage, S., & Webb, D. J. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003952 · Cited by 2
Management of Hypertension in Chronic Kidney Disease
Rahman, M., Drawz, P. E., Thomas, G., & Turner, J. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00061-9 · Cited by 2
Self-citationYahr, J., Calle, J., & Taliercio, J. J. (2021) · Journal of Osteopathic Medicine · doi:10.1515/jom-2021-0150 · Cited by 2
“1%were controlledbelowasystolicblood pressure (SBP)/diastolic bloodpressure (DBP) <130/80mmHg [12].”
Quiroga, B., Arroyo, D., & de la Fuente, G. D. A. (2019) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2019.06.002 · Cited by 3
Antihypertensive Medication in Patients Pre- and Postdialysis: Still Hazy After All These Years
Cohen, J. B., & Townsend, R. R. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06130616 · Cited by 1
Self-citationNagahama, A. M., Silva, V. D. S., Banin, V. B., Franco, R. J. D. S., Barretti, P., Bazan, S. G. Z., & Martín, L. C. (2024) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2023-0066pt · Cited by 1
Amer, S. B., Al-Slati, Y., Badawneh, L., Hanib, A. B., Al-Wakfi, K., Zghoul, R., Al-As-hab, R., Amer, R. B., Al-Shorman, H., Al-Khateeb, H., et al. (2024) · medtigo Journal of Medicine · doi:10.63096/medtigo30622412 · Cited by 1
Hypertension Management Dynamics in Pediatric CKD: Insights From the 4C Study
Doyon, A., Bayazıt, A. K., Düzova, A., Thurn, D., Canpolat, N., Bulut, İ. K., Ažukaitis, K., Obrycki, Ł., Ranchin, B., Shroff, R. C., et al. (2025) · Hypertension · doi:10.1161/hypertensionaha.124.24330 · Cited by 1
Danneel, C., Sauvage, C., Hayef, M. N., Desmet, V., Surquin, M., Nortier, J., & Vriese, C. D. (2025) · Biomedicines · doi:10.3390/biomedicines13040994 · Cited by 1
Enache, I. I., Manea, M. M., Tuță, S., & Sîrbu, C. A. (2025) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2025.108981 · Cited by 2
“Hypertension is one such example, as it is the risk factor of greatest importance in ICH [138], [139], [140] and it virtually appears in almost all patients suffering from CKD, triggered by the renin-angiotensin system (RAS) being activated and sodium buildup [141], [142].”
Huang, J., Lourenço, B. N., Schmiedt, C. W., Tarigo, J. L., & Coleman, A. E. (2025) · Physiological Reports · doi:10.14814/phy2.70417 · Cited by 1
Sikaneta, T., Martin, S., Mucsi, I., Lofters, A., Taşkapan, H., Tam, P. Y., & Mahdavi, S. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-105083 · Cited by 1
Chang, T. I., Cluett, J., Cohen, D. L., Drawz, P. E., Hudson, J. Q., Kramer, H., Rahman, M., & Awdishu, L. (2026) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2026.07.006 · Cited by 1
Self-citationEthnicity and Chronic Kidney Disease in China
Gao, B., Wang, J., Zhang, L., & Zhuang, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00012-7 · Cited by 1
Bobrie, G., Amar, L., Faucon, A., Madjalian, A.-M., & Azizi, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42973-3.00043-3 · Cited by 1
Cardiovascular Disease in Chronic Kidney Disease
Sarnak, M. J., & Weiner, D. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52978-5.00012-4 · Cited by 1
Bae, S. R., McCulloch, C. E., Hsu, R. K., & Ku, E. (2021) · Open Access Journal of Clinical Trials · doi:10.2147/oajct.s311821 · Cited by 1
“16 First, intensive BP control would require the use of additional antihypertensive agents.”
Goldman, J. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-83082-3_7 · Cited by 1
THE PARTICULARITIES OF ABPM PARAMETERS IN HYPERTENSIVE PATIENTS WITH NON-DIALYSIS CKD
Mincă, A., Comşa, M. O., Manea, M. M., Tănăsescu, M. D., Dragoș, D., Penescu, M. N., & Ionescu, D. (2017) · Romanian Medical Journal · doi:10.37897/rmj.2017.4.3 · Cited by 1
Management of hypertension in advanced kidney disease
Georgianos, P. I., & Agarwal, R. (2022) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000812 · Cited by 1
Antihypertensive therapy in comorbid patients with chronic kidney disease: case report
Ebzeeva, E. Y., Ostoroumova, O. D., & Doldo, N. M. (2023) · Russian Medical Inquiry · doi:10.32364/2587-6821-2023-7-7-3 · Cited by 1
Lin, H. Y., Chang, Y.-H., Wang, Y., Liang, P., Hung, C., Chang, J., Dai, D., Lin, C., & Chang, K. (2023) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.202359 · Cited by 1
Chronic kidney disease associated with hypertension
Ali, S. M., Liu, Z., & Hassan, S. (2023) · World Journal of Biology Pharmacy and Health Sciences · doi:10.30574/wjbphs.2023.16.3.0509 · Cited by 1
Yoon, S., Kong, J. Y., Jeong, S. J., Kim, J. S., Hwang, H. S., & Jeong, K.-H. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032186 · Cited by 1
Revisiting Hypertension Treatment in Patients With Chronic Kidney Disease
Hernandez, M. F., & Chang, T. I. (2024) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2024.151514 · Cited by 2
Sharma, A., Bhusal, L., Rajbhandari, A., Maharjan, S., Adhikari, A., & Aryal, E. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002377 · Cited by 1
SHELKE, K., Parkhe, T. S., & SHINDE, D. (2025) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2025v17i8.54827 · Cited by 1
Resistant hypertension matters in chronic kidney disease
Hilgers, K. F. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.131 · Cited by 1
Omboni, S., & Borghi, C. (2019) · Current Clinical Pharmacology · doi:10.2174/1574884713666181025145404 · Cited by 1
Rivera, M., Tamariz, L., Suarez, M. M., & Contreras, G. (2019) · American Journal of Nephrology · doi:10.1159/000499188 · Cited by 2
Oschepkova, E. V., Владимировна, А. А., Александрович, О. А., & Chazova, I. E. (2019) · Terapevticheskii arkhiv · doi:10.26442/00403660.2019.09.000356 · Cited by 1
Nonatherosclerotic Vascular Abnormalities Associated with Chronic Kidney Disease
Mohandas, R., Chamarthi, G., & Segal, M. S. (2021) · Cardiology Clinics · doi:10.1016/j.ccl.2021.04.012 · Cited by 1
Prediction of unfavorable outcome in ischemic stroke patients with chronic kidney disease
Antonenko, A., Antonenko, K., Vakulenko, L., & Dubovenko, Z. O. (2021) · Ukrainian Journal of Nephrology and Dialysis · doi:10.31450/ukrjnd.4(72).2021.07 · Cited by 1
Pathophysiology of Hypertension in Chronic Kidney Disease
Townsend, R. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00021-8 · Cited by 1
Self-citationJo, S. (2016) · Korean Journal of Medicine · doi:10.3904/kjm.2016.90.5.378 · Cited by 1
Use of Thiazides to Treat Hypertension and Advanced CKD
Priamvada, G. S., Divyadarshini, D. S., & Voora, R. A. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01817-y · Cited by 1
Dương, Q. H., & Đỗ, D. L. (2023) · Tạp chí Tim Mạch Học Việt Nam · doi:10.58354/jvc.104.2023.271 · Cited by 1
Manolis, A. J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734299250.793571584 · Cited by 1
H-type hypertension is a risk factor for chronic kidney disease: a case-control studyPreprint
Long, T., Zheng, L., Ding, Z., Yu, T., & Hong, X. (2024) · Research Square · doi:10.21203/rs.3.rs-3992934/v1 · Cited by 1
van Zuilen, A. D. (2011) · Utrecht University Repository (Utrecht University)
Jain, P. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
Muñoz, E. Y. A., & Echeverry, O. Y. (2012) · Dialnet (Universidad de la Rioja)
The Heterogeneity and Diversity of Hypertension in CKD
Goldman, J. M., Cohen, D. L., & Sim, J. J. (2015) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.12.003
Epidemiology of Hypertension in Chronic Kidney Disease
Wang, A. Y.-M. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6436-9_1
Cibles de pression artérielle en néphrologie en 2017
Guerrot, D., & Godin, M. (2017) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2017.01.010
Ardati, A. K. (2017) · Springer eBooks · doi:10.1007/978-3-319-56042-7_21
Pathophysiological Insights of Hypertension in Patients with Chronic Kidney Disease
Turgut, F. H., Yaprak, M., & Tokmak, F. (2017) · Springer eBooks · doi:10.1007/978-3-319-56827-0_8
Borrelli, S., Nicola, L. D., Conte, G., & Minutolo, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-56827-0_4
Turner, J. M., & Sharma, D. R. (2018) · Springer eBooks · doi:10.1007/978-3-319-20317-1_17-1
Chronische, nicht dialysepflichtige Niereninsuffizienz
Reshetnik, A. (2018) · Dialyse aktuell · doi:10.1055/a-0555-5070
“Die Prävalenz des arteriellen Hypertonus steigt mit abnehmender Nierenfunktion [1].”
BackgroundInfluentialGarimella, P. S., & Miskulin, D. C. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7784-0_12
Clementi, A., Virzì, G. M., Brocca, A., & Ronco, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00114-x
Chronic Kidney Disease in the Primary Care Setting: Cardiovascular Disease Risk and Management
Lakkis, J. I., & Weir, M. R. (2018) · Contemporary cardiology · doi:10.1007/978-3-319-97622-8_8
Self-citation郭, 文. (2019) · Advances in Clinical Medicine · doi:10.12677/acm.2019.98151
Karinda, T. U. S., Sugeng, C. E. C., & Moeis, E. S. (2019) · e-CliniC · doi:10.35790/ecl.7.2.2019.26878
Significance Of Circulating Adipocytokines In Hypertensive Patients With Chronic Kidney Disease
Korzh, O., Krasnokutskiy, S., KUDEY, A., & Fylenko, Y. (2020) · Archives of the Balkan Medical Union · doi:10.31688/abmu.2020.55.2.05
Blutdruck bei Niereninsuffizienz
Zidek, W. (2020) · Dialyse aktuell · doi:10.1055/a-1216-4639
Studies Exploring Non-Adherence in Adult Renal Transplant Recipients
Hucker, A. (2020) · University of Hertfordshire Research Archive (University of Hertfordshire) · doi:10.18745/th.23573
Hussain, M. S., Raza, Q. S., Aamir, M. O., Murtaza, N., Naureen, S., & Razzaq, M. (2021) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v71i1.2489
Cam, T. D., Anh, T. H., Le, H. T., Kieu, N. D., & Hoang, T. A. (2021) · Genetics and Molecular Research · doi:10.4238/gmr18729
Total solar eclipse : a Caribbean adventure
Green, S., Tunstall, L., & Tunstall, N. (1999) · School science review
Boiko, O. V., & Родіонова, В. В. (2021) · KIDNEYS · doi:10.22141/2307-1257.10.4.2021.247893
Ghazi, L., Shimbo, D., Jacobs, D. R., Kramer, H., Cohen, J. B., Muntner, P., Yano, Y., & Drawz, P. E. (2021) · Kidney Medicine · doi:10.1016/j.xkme.2021.10.015
Self-citationChronic Kidney Disease affecting the Characteristics of Blood Pressure: An Observational Study
Sumanth, B. V. (2021) · Journal of Advanced Research in Medicine · doi:10.24321/2349.7181.202116
CHRONIC RENAL DISEASE AND CEREBROVASCULAR PATHOLOGY (LITERATURE REVIEW)
Delva, I. I. (2022) · Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії · doi:10.31718/2077-1096.22.1.175
Turner, J. M., & Sharma, D. R. (2020) · Springer eBooks · doi:10.1007/978-3-319-47771-8_17
Townsend, R. R., & Sica, D. A. (2011) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2010.10.005
Self-citationGeorgianos, P. I., Vaios, V., Sgouropoulou, V., & Liakopoulos, V. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003149
Blood Pressure Control in Primary Care
Brown, L., Williamson, J. D., & Bowling, C. B. (2022) · Contemporary cardiology · doi:10.1007/978-3-030-98824-1_5
Causes, Evaluation, and Treatment of Secondary and Resistant Hypertension
Hundemer, G. L. (2022) · Nephrology Self-Assessment Program · doi:10.1681/nsap.00082022
Wang, C., Huang, H., Lyu, Y., Li, X., Wang, X., Chang, Q., Wang, K., Liu, Y., Gao, J., Cui, Z., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2245616/v1
Hiremath, S. S. (2022) · Wiley eBooks · doi:10.1002/9781119105954.ch22
Владимировна, А. А., Ощепкова, Е. В., Orlovsky, А. A., & Chazova, I. E. (2022) · Systemic Hypertension · doi:10.38109/2075-082x-2022-2-39-46
Tirmenštajn‐Janković, B., & Bastać, D. (2022) · Timocki medicinski glasnik · doi:10.5937/tmg2202084t
Oporto, F. J. R., Aguilera, A. L., Cosano, G. M., & Gómez, C. A. (2023) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2023.03.001
Research Progress Based on Serious Complication of Stroke in Patients with Chronic Kidney Disease
Tian, Y., Zhu, Q., Tang, Y., Li, R., & Xiao, J. (2023) · Current Research in Medical Sciences · doi:10.56397/crms.2023.06.07
Subramanya, A. M., Khan, M. F., & Ravindra, A. (2023) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20232091
Nunes, J. A. W., Resnicow, K., Richardson, C. R., Levine, D., Kerr, E. A., Saran, R., Gillespie, B. W., Bragg‐Gresham, J. L., Delacroix, E., Considine, S., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-071318
Accelerated Atherosclerosis in the Setting of Chronic Kidney Disease
Reiss, A. B., Glass, A. D., Renna, H. A., Grossfeld, D. J., Glass, D. S., Kasselman, L. J., & Leon, J. D. (2019) · Archives of Nephrology · doi:10.22259/2639-3573.0201002
Hypertension and Chronic Kidney Disease
Georgianos, P. I., & Agarwal, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-42045-0_5
Manejo odontológico de pacientes com Doença Renal Crônica: Uma revisão de literatura
de Souza, W. L. M., dos Santos, L. H., Carvalho, T. D. A., & Júnior, H. M. (2023) · Research Society and Development · doi:10.33448/rsd-v12i13.44265
Kim, Y., Kim, J., Kang, E., Im, D. W., Kim, T. H., Huh, H., Kim, Y. H., Lee, H., Kim, J. H., & Oh, K. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003625
“Management of Emerging or Unconventional Risk Factors-2”
Miwa, K., & Toyoda, Ḱ. (2024) · Springer eBooks · doi:10.1007/978-3-031-49963-0_12
Mamven, M., Adejumo, O. A., Ajayi, S. O., & Egbi, O. G. (2024) · PubMed Central · doi:10.60787/nmj-63-5-140
Renal denervation benefits in chronic kidney disease: An updated review
Habas, E. M., Alarbi, K. M. S., Habas, A. M., Baghi, M. A. M., Habas, E., Rayani, A., Said, A., Farfar, K., Errayes, A., Alfitori, G. B., et al. (2024) · Yemen Journal of Medicine · doi:10.18231/j.yjom.2024.004
Metadata
- Authors
- Muntner, P., Anderson, A., Charleston, J., Chen, Z., Ford, V., Makos, G., O'Connor, A., Perumal, K., Rahman, M., Steigerwalt, S., Teal, V., Townsend, R., Weir, M., & Wright, J. T.
- Affiliations
- University of Alabama at Birmingham (US)
- University of Pennsylvania (US)
- University of Maryland, Baltimore (US)
- National Institutes of Health (US)
- University of Illinois Chicago (US)
- University Hospitals Cleveland Medical Center (US)
- St. John Medical Center (US)
- Case Western Reserve University (US)
- Corresponding author
- Muntner, Paul
- ORCID
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 55
- Issue
- 3
- Pages
- 441-451
- ISSN
- 0272-6386 (ISSN-L)
- PMC
- PMC2866514
- OpenAlex
- W2096512601
- Cited by
- 423
- References
- 16
- Citations by year
- 2026: 10 · 2025: 34 · 2024: 32 · 2023: 45 · 2022: 34 · 2021: 35 · 2020: 33 · 2019: 40 · 2018: 32 · 2017: 23 · 2016: 20 · 2015: 19 · 2014: 13 · 2013: 16 · 2012: 17
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Kidney Diseases (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (5U01DK06102, U01DK060990, 5U01 DK60980, T32DK007785, T32DK060455, K01DK064860, U01DK060984, U01DK060902, U01DK060980, U01DK060963, U01DK061021, U01DK061028)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- hypertension, chronic kidney disease, blood pressure control, hypertension awareness, antihypertensive medication use, ACE inhibitors, angiotensin receptor blockers, urinary albumin excretion, Chronic Renal Insufficiency Cohort Study, older adults, racial disparities
- MeSH terms
- Adult, Aged, Chronic Disease, Female, Humans, Hypertension, Kidney Diseases, Male, Middle Aged, Renal Insufficiency, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review